Long-term outcome of surgically and medically treated patients with gastroesophageal reflux disease: A matched-pair follow-up study

Scandinavian Journal of Gastroenterology

Volumn 40, Issue 3, 2005, Pages 264-274

  Olberg, Petter ^a   Johannessen, Rune ^a   Johnsen, Gjermund ^a   Myrvold, Helge E ^a   Bjerkeset, Tormod ^b   Fjösne, Ulf ^b   Petersen, Hermod ^a  

^a TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^b Levanger Hospital   (Norway)

Author keywords

Esophagitis; Fundoplication; Laparoscopy; Medical treatment; Quality of life assessment; Symptom assessment

Indexed keywords

PROTON PUMP INHIBITOR;

ADULT; ANTIREFLUX OPERATION; ARTICLE; BARRETT ESOPHAGUS; CLINICAL PRACTICE; COMPARATIVE STUDY; CONTROLLED STUDY; ESOPHAGITIS; FEMALE; FOLLOW UP; GASTROESOPHAGEAL REFLUX; HIATUS HERNIA; HUMAN; HUMAN TISSUE; LAPAROSCOPIC SURGERY; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RATING SCALE; STATISTICAL ANALYSIS; STOMACH FUNDOPLICATION; TREATMENT OUTCOME; WELLBEING;

ENZYME INHIBITORS; FEMALE; FOLLOW-UP STUDIES; FUNDOPLICATION; GASTROESOPHAGEAL REFLUX; HISTAMINE H2 ANTAGONISTS; HUMANS; LAPAROSCOPY; MALE; MATCHED-PAIR ANALYSIS; MIDDLE AGED; PATIENT SATISFACTION; PROTON PUMPS; QUALITY OF LIFE; QUESTIONNAIRES; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME;

EID: 16444376081     PISSN: 00365521     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365520510011588     Document Type: Article

References (44)

1. Petersen H. The prevalence of gastro-oesophageal reflux disease. Scand J Gastroenterol 1995;30(Suppl 211):5-6.
2. Jones R. Gastro-oesophageal reflux disease in general practice. Scand J Gastroenterol 1995;30(Suppl 21):35-8.
3. Wiklund I. Quality of life in patients with gastroesophageal reflux disease. Am J Gastroenterol 2001;96(Suppl 8):S46-52.
4. Dent J, Talley NJ. Overview: Initial and long-term management of gastroesophageal reflux disease. Aliment Pharmacol Ther 2003;17(Suppl 1):53-7.
5. Jones R, Bytzer P. Review article: Acid suppression in the management of gastro-oesophageal reflux disease - an appraisal of treatment options in primary care. Aliment Pharmacol Ther 2001;15:765-72.
6. Bardhan KD. Intermittent and on-demand use of proton pump inhibitors in the management of symptomatic gastroesophageal reflux disease. Am J Gastroenterol 2003;98 (Suppl 3):S40-8.
7. Wilhelmsen I, Hatlebakk JG, Olafsson S, Berstad A. On demand therapy of reflux esophagitis: A prospective study of symptoms, patient satisfaction and quality of life. Aliment Pharmacol Ther 1999;13:1035-40.
8. Waldum HL, Brenna E. Personal review: Is profound acid inhibition safe? Aliment Pharmacol Ther 2000;14:15-22.
9. Grande L, Toledo-Pimentel V, Manterola C, Lacima G, Ros E, Garcia-Valdecasis JC, Fuster J, Visa J, Pera C. Value of Nissen fundoplication in patients with gastroesophageal reflux judged by long-term symptom control. Br J Surg 1994;81:548-50.
10. Lundell L, Dalenbäck J, Hattlebakk J, Janatuinen E, Levander K, Miettinen P, Myrvold HE, Pedersen SA, Thor K, Junghard O, Andersson A. Outcome of open antireflux surgery as assessed in a Nordic multicentre prospective clinical trial. Eur J Surg 1998;164:751-7.
11. Hagedorn C, Lönroth H, Rydberg L, Ruth M, Lundell L. Long-term efficacy of total (Nissen-Rossetti) and posterior partial (Toupet) fundoplication: Results of a randomized clinical trial. J Gastrointest Surg 2002;6:540-5.
12. Campos GMR, Peters J, DeMeester TR, Øberg S, Crookes PF, Tab S, DeMeester SR, Hagen JA, Bremnes CG. Multivariate analysis of factors predicting outcome after laparoscopic Nissen fundoplication. J Gastrointest Surg 1999;3: 292-300.
13. Eubanks TR, Omelanczuk P, Richards C, Pohl D, Pellegrini AP. Outcome of laparoscopic antireflux procedures. Am J Surg 2000;179:391-5.
14. Bammer T, Hinder RA, Klaus A, Kringler PJ. Five- to eight-year outcome of the first laparoscopic Nissen fundoplications. J Gastrointest Surg 2001;5:42-8.
15. Anvari M, Allen C. Five-year comprehensive outcomes evaluation in 181 patients after laparoscopic Nissen fundoplication. J Am Coll Surg 2003;196:51-7.
16. Watson DI, de Beaux AC. Complications of laparoscopic antireflux surgery. Surg Endosc 2001;15:344-52.
17. Rantanen TK, Salo JA, Sipponen JT. Fatal and life-threatening complications in antireflux surgery: Analysis of 5502 operations. Br J Surg 1999;86:1573-7.
18. Behar J, Sheahan DG, Biancani P, Spiro HM, Storer EH. Medical and surgical management of reflux esophagitis. A 38 month report on a prospective clinical trial. N Engl J Med 1975;293:263-8.
19. Spechler JS. Comparison of medical and surgical therapy for complicated gastroesophageal reflux disease in veterans. N Engl J Med 1992;326:786-92.
20. Spechler SJ, Lee E, Ahnen D, Goyal RK, Hirano I, Ramirez F, Raufmann JP, Sampliner R, Schnell T, Sontag S, Viacevic R, Young R, Williford W. Long-term outcome of medical and surgical therapies for gastroesophageal reflux disease. Follow-up of randomized controlled trial JAMA 2001;285:2331-8.
21. Lundell L, Miettinen P, Myrvold HE, Pedersen SA, Thor K, Lamm M, et al. Long-term management of gastro-esophageal reflux disease with omeprazole or open antireflux surgery: Results of a prospective, randomized clinical trial. Eur J Gastroenterol Hepatol 2000;12:879-87.
22. Johanson JF, Siddique R, Damiano AM, Jokubaitis L, Murthy A, Bhattacharjya A. Rabeprazole improves health-related quality of life in patients with erosive gastroesophageal reflux disease. Dig Dis Sci 2002;47:2574-8.
23. Kulig M, Leodolter A, Vieth M, Schulte E, Jaspersen D, Labenz J, Lind T, Meyer-Sabellek W, Malfertheiner P, Stolte M, Willich N. Quality of life in relation to symptoms in patients with gastro-oesophageal reflux disease: An analysis based on the ProGERD initiative. Aliment Pharmacol Ther 2003;18:767-76.
24. Trus TL, Laycock WS, Waring JP, Branum GD, Hunter JG. Improvement in quality of life measures after laparoscopic antireflux surgery. Ann Surg 1999;229:331-6.
25. Rattner DW. Measuring improved quality of life after laparoscopic Nissen fundoplication. Surgery 2000;127:258-63.
26. Savary M, Miller G. The oesophagus: Handbook and atlas of endoscopy. Solothurn, Switzerland: Gassmann AG; 1978.
27. Svedlund J, Sjödin I, Dotevall G. GSRS: A clinical rating scale for gastrointestinal symptoms in patients with irritable bowel syndrome and peptic ulcer disease. Dig Dis Sci 1988;33:129-34.
28. Revicki DA, Wood M, Wiklund I, Crawley J. Reliability and validity of the gastrointestinal symptom rating scale in patients with gastroesophageal reflux disease. Qual Life Res 1998;7:75-83.
29. Dupuy HJ. The physiological general well-being (PGWB) index. In: Wenger NK, Mattson ME, Furberg CF, Elinson J, editors. Assessment of quality of life in clinical trials of cardiovascular therapies. Darien, CT: Le Jacq Publishing Inc; 1984. pp 170-83.
30. Talley NJ, Fullerton S, Junghard O, Wiklund I. Quality of life in patients with endoscopy-negative heartburn: Reliability and sensitivity of disease-specific instruments. Am J Gastroenterol 2001;96:1998-2004.
31. Dimenäs E, Carlsson G, Glise H, Israelsson B, Wiklund I. Relevance of norm values as part of the documentation of quality of life instruments for use in upper gastrointestinal disease. Scand J Gastroenterol 1996;31(Suppl 221):8-13.
32. Revicki DA, Crawley JA, Zodet MW, Levine DS, Joelsson BO. Complete resolution of heartburn symptoms and health-related quality of life in patients with gastro-esophageal reflux disease. Aliment Pharmacol Ther 1999;13:1621-30.
33. Juniper EF, Guyatt GH, Willan A, Griffith LE. Determining a minimal important change in a disease-specific quality of life questionnaire. J Clin Epidemiol 1994;47:81-7.
34. Glise H, Hallerbäck B, Johansson B. Quality-of-life in evaluation of laparoscopic Rosetti fundoplication. Surg Endosc 1995;9:183-9.
35. Peters JH, Heimbucher J, Kauer WKH, Incarbone R, Bremner CG, DeMeester TR. Clinical and physiologic comparison of laparoscopic and open Nissen fundoplication. J Am Coll Surg 1995;180:385-93.
36. O'Boyle CJ, Watson DI, deBeaux AC, Jamieson GG. Preoperative prediction of long-term outcome following laparoscopic fundoplication. ANZ J Surg 2002;72:471-5.
37. Desai KM, Frisella MM, Soper NJ. Clinical outcomes after laparoscopic antireflux surgery in patients with and without preoperative endoscopic esophagitis. J Gastrointest Surg 2003;7:44-51.
38. Trimble KC, Douglas S, Pryde A, Heading RC. Clinical characteristics and natural history of symptomatic but not excess gastroesophagal reflux. Dig Dis Sci 1995;40:1098-104.
39. McDougall NI, Johnston BT, Kee F, Collins JSA, McFarland RJ, Love AHG. Natural history of reflux oesophagitis: A 10 year follow up of its effect on patient symptomatology and quality of life. Gut 1996;38:481-6.
40. McDougall NI, Johnston BT, Collins JSA, McFarland RJ, Love AHG. Disease progression in gastroesophagal reflux disease as determined by repeat oesophageal pH monotoring and endoscopy 3 to 4.5 years after diagnosis. Eur J Gastroenterol Hepatol 1997;9:1161-7.
41. Klaus A, Hinder RA, DeVault KR, Achem SR. Bowel dysfunction after laparoscopic antireflux surgery: Incidence, severity and clinical course. Am J Med 2003;114:6-9.
42. Richter JE. Let the patient beware: The evolving truth about laparoscopic antireflux surgery. Am J Med 2003;114:71-3.
43. Klapow JC, Wilcox CM, Mallinger AP, Marks R, Heudebert GR, Centor RM, Lawrence W, Richter J. Characterization of long-term outcomes after Toupet fundoplication. Symptoms, medication use, and health status. J Clin Gastroenterol 2002;34:509-15.
44. Vakil N, Shaw M, Kirby R. Clinical effectiveness of laparoscopic fundoplication in a U.S. community. Am J Med 2003;114:1-5.